The Frequency of Histologically Dysplastic Nevi in 199 Pediatric Patients
dc.contributor.author | Haley, Jennifer C. | en_US |
dc.contributor.author | Hood, Antoinette F. | en_US |
dc.contributor.author | Chuang, Tsu-Yi | en_US |
dc.contributor.author | Rasmussen, James E. | en_US |
dc.date.accessioned | 2010-06-01T22:07:07Z | |
dc.date.available | 2010-06-01T22:07:07Z | |
dc.date.issued | 2000-07 | en_US |
dc.identifier.citation | Haley, Jennifer C.; Hood, Antoinette F.; Chuang, Tsu-Yi; Rasmussen, James (2000). "The Frequency of Histologically Dysplastic Nevi in 199 Pediatric Patients." Pediatric Dermatology 17(4): 266-269. <http://hdl.handle.net/2027.42/75141> | en_US |
dc.identifier.issn | 0736-8046 | en_US |
dc.identifier.issn | 1525-1470 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/75141 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10990573&dopt=citation | en_US |
dc.format.extent | 87504 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Inc | en_US |
dc.rights | Blackwell Science, Inc. | en_US |
dc.title | The Frequency of Histologically Dysplastic Nevi in 199 Pediatric Patients | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Dentistry | en_US |
dc.subject.hlbsecondlevel | Pediatrics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Dermatology, University of Michigan School of Medicine, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationother | Department of Medicine, University of California, Los Angeles, Los Angeles, California, Departments of | en_US |
dc.contributor.affiliationother | Pathology and Laboratory Medicine and | en_US |
dc.contributor.affiliationother | Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, and | en_US |
dc.identifier.pmid | 10990573 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/75141/1/j.1525-1470.2000.01772.x.pdf | |
dc.identifier.doi | 10.1046/j.1525-1470.2000.01772.x | en_US |
dc.identifier.source | Pediatric Dermatology | en_US |
dc.identifier.citedreference | Katz SI, ed. Precursors to malignant melanoma. Am J Dermatopathol 1984; 6 ( suppl 1 ): 169 174. | en_US |
dc.identifier.citedreference | Kraemer KH, Greene MH, Tarone R, Elder DE, Clark Wh Jr, Guerry D IV. Dysplastic naevi and cutaneous melanoma risk. Lancet 1983; 2: 1076 1077. | en_US |
dc.identifier.citedreference | Kraemer KH. Dysplastic nevi as precursors to hereditary melanoma. J Dermatol Surg Oncol 1983; 9: 619 622. | en_US |
dc.identifier.citedreference | Clark Wh Jr, Reimer RR, Greene MH, Ainsworth AM. Origin of familial malignant melanomas from heritable melanocytic lesions: the B-K mole syndrome. Arch Dermatol 1978; 114: 732 738. | en_US |
dc.identifier.citedreference | Augustsson A, Stierner U, Suukula M, Rosdahl I. Prevalence of common and dysplastic naevi in a Swedish population. Br J Dermatol 1991; 124: 152 156. | en_US |
dc.identifier.citedreference | Barnhill R, Kiryu H, Sover AJ, Mihm Mc Jr. Frequency of dysplastic nevi among nevomelanocytic lesions submitted for histopathologic examination. Arch Dermatol 1990; 126: 463 465. | en_US |
dc.identifier.citedreference | Crutcher WA & Sagebiel RW. Prevalence of dysplastic naevi in a community practice. Lancet 1984; I: 729. | en_US |
dc.identifier.citedreference | Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17: 459 468. | en_US |
dc.identifier.citedreference | Stierner U, Augustsson A, Rosdahl I, Suurkula M. Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure: a case-control study. Melanoma Res 1991; 1: 367 375. | en_US |
dc.identifier.citedreference | Nordlund JJ, Kirkwood J, Forget BM, et al. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 1985; 45: 1855 1861. | en_US |
dc.identifier.citedreference | Newton JA, Bataille B, Griffiths K, et al. How common is the atypical mole syndrome phenotype in apparently sporadic melanoma? J Am Acad Dermatol 1993; 29: 989 996. | en_US |
dc.identifier.citedreference | Piepkorn M, Meyer LJ, Goldgar D, et al. The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol 1989; 20: 407 415. | en_US |
dc.identifier.citedreference | Novakovic B, Clark Wh Jr, Fears TR, Fraser MC, Tucker MA. Melanocytic nevi, dysplastic nevi, and malignant melanoma from melanoma-prone families. J Am Acad Dermatol 1995; 33: 631 636. | en_US |
dc.identifier.citedreference | Rivers JK, MacLennan R, Kelly JW, et al. The eastern Australian childhood nevus study: prevalence of atypical nevi, congenital nevus-like nevi, and other pigmented lesions. J Am Acad Dermatol 1995; 32: 957 963. | en_US |
dc.identifier.citedreference | Clemente C, Cochran AJ, Elder DE, et al. Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. Hum Pathol 1991; 22: 313 319. | en_US |
dc.identifier.citedreference | Reeck MC, Chuang TY, Eads TJ, Faust HB, Farmer ER, Hood AF. The diagnostic yield in submitting nevi for histologic examination. J Am Acad Dermatol 1999; 40: 567 571. | en_US |
dc.identifier.citedreference | Rothman KF & Esterly NB. Dysplastic nevi in children. Pediatr Dermatol 1990; 7: 218 234. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.